NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

HyGro,

I just have several questions and I would appreciate your honest answers.

1. Can you explain why over 90% percent patients were recruited in the last five years of the trial?

2. If everything is as bad as you depict, why did BMY come for collaboration with NWBO? BMY seems like holding no grievance after the collaboration deal was withdrawn last and plans to collaborate on another combo trial.

3. You do know the expanded access program for dcvax which started about the time when the trial was finished. How could FDA approve such program if DcVax had a bad record and after the partial hold?

https://clinicaltrials.gov/ct2/show/NCT02146066?cond=Expand+%2B+dcvax&draw=2&rank=1

4. The data from Linda Liau's latest present which has close 60% patients living over 800 days is based on dcvax. You would agree, right?

5. Do you agree that there were patients who dropped out the trial because the pseudoprogression was unknown back then and was considered as true progression?